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Alpha-enolase is a key glycolytic enzyme that plays a functional role in several physiological processes depending on the cellular localization.
The enzyme is mainly localized in the cytoplasm whereas an alternative translated form, named MBP-1, is predominantly nuclear. The MBP-1
protein has been characterized as a c-Myc promoter binding protein that negatively controls transcription. In the present study, we identified the
kelch protein NS1-BP as one of the alpha-enolase/MBP-1 partners by using a yeast two-hybrid screening. Although NS1-BP has been originally
described as a protein mainly localized in the nucleus, we provide evidence that NS1-BP also interacts with actin in human cells, as reported for
most kelch-containing proteins. Here we showed that alpha-enolase andMBP-1 associate with NS1-BP in vitro and in vivo byGST pull-down assays
and coimmunoprecipitation experiments; subsequent immunofluorescent staining confirmed colocalization of the proteins within the cells.
Furthermore, functional analyses performed by cotransfection assays revealed that NS1-BP enhances the inhibitory effect exerted by MBP-1 on c-
Myc promoter. In mammalian cells, the overexpression of both proteins resulted in an increased repression of basal c-Myc transcription and
consistently affected the steady state levels of endogenous c-Myc mRNA. These findings further support the distinct roles of alpha-enolase and its
MBP-1 variant in maintaining cell homeostasis. Moreover, our data suggest a novel function for NS1-BP in the control of cell proliferation.
© 2007 Elsevier B.V. All rights reserved.Keywords: Kelch proteins; Enolase; Glycolysis; c-Myc transcription; Yeast two-hybrid assay1. Introduction
Enolase (2-phospho-D-glycerate hydrolase) (EC 4.2.1.11) is
a dimeric enzyme belonging to the glycolytic pathway that
catalyzes the reversible conversion of 2-phosphoglycerate to
phophoenolpyruvate in both glycolysis and gluconeogenesis.
In mammals, three different enolase isoforms exist: alpha- beta-
and gamma-enolase, which are encoded by three distinct genes
and expressed in a tissue- and development-specific manner⁎ Corresponding author. Università di Palermo, Dipartimento di Oncologia
Sperimentale ed Applicazioni Cliniche, Via San Lorenzo Colli, 312, I-90146
Palermo, Italy. Tel.: +39 091 6806419; fax: +39 091 6806418.
E-mail address: feo@unipa.it (S. Feo).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.09.002[1–3]. The alpha-isoform is the embryonic form present also in
most adult tissues, where its expression is finely tuned in
several physiopathological conditions, in addition to its
housekeeping role. Alpha-enolase expression increases upon
mitogenic stimulation in lymphocytes [4], following inflam-
matory stimuli and cytokines production [5,6] and under
hypoxic conditions [7].
Several studies have shown that, besides its major role in
glycolysis, alpha-enolase is a multifunctional protein displaying
a range of distinct activities: it is a hypoxic stress protein in
endothelial cells, a heat shock protein in yeast, a lens crystallin
and an autoimmune antigen [8]. Moreover, in addition to its
primary localization in the cytoplasm, alpha-enolase is also
expressed on the surface of a variety of eukaryotic cells,
where it functions as a plasminogen receptor (reviewed in [9]).
1775G. Perconti et al. / Biochimica et Biophysica Acta 1773 (2007) 1774–1785Furthermore, nuclear alpha-enolase immunoreactivity has been
detected in proliferating myoblasts [10] and one short form of
enolase arising from alternative translation was found with a
mainly nuclear localization [11–13]. This short variant lacks the
first 96 amino acids and is named MBP-1 (c-Myc promoter-
Binding Protein 1) based on its ability to bind and negatively
regulate the major c-Myc gene promoter (P2) [14–16]. A
number of in vitro studies have indicated that MBP-1 exerts an
antiproliferative effect in various human cancer cells [17,18]
and its overexpression induces tumor growth regression in nude
mice [19,20].
Altogether, these findings suggest that alpha-enolase may
play a unique role in many physiological processes. Neverthe-
less, more detailed and non-overlapping potential functions of
the protein remain far from being understood. For example,
little is known about the molecular mechanisms that regulate
enolase/MBP-1 nuclear or membrane transport although the
lack of canonical localization signals suggests the possible
involvement of other proteins in the nuclear import and mem-
brane anchorage. To date two proteins have been identified for
their ability to bind MBP-1, the histone deacetylase HDAC1
[21] and MIP2A/sedlin, a protein with a putative role in
endoplasmic reticulum-to-Golgi transport [22].
Since the identification of additional protein–protein inter-
actions could contribute to elucidate the activities of alpha-
enolase/MBP-1 within the distinct cell compartments, we were
prompted to isolate novel partners by a yeast two-hybrid screening
using the full-length alpha-enolase as bait and a human cDNA
library.
In this study we demonstrated that NS1-BP, a member of the
kelch-repeat family of proteins [23,24] belonging to the BTB-
kelch proteins subgroup, interacts with both alpha-enolase and its
MBP-1 variant in vitro and in vivo. The BTB-kelch proteins
subgroup is classified according to the associated BTB/POZ
domain, an evolutionarily conserved domain that mediates
protein–protein interactions [25].
Kelch-containing proteins are known to be involved in many
aspects of cell function and it has been reported a variety of
cellular distributions and functions despite these proteins are
often associated with the cytoskeleton system [24]. NS1-BP has
been shown to have a primary nuclear localization [23], here we
confirmed that the protein interacts with actin filaments, in
accordance with what was previously found for the mouse
homologue. Furthermore, we demonstrated an additional
nuclear function showing that NS1-BP may act in association
with MBP-1 and potentiate its repressor activity on c-Myc
promoter. Our data uncover a novel role for NS1-BP in the
regulatory control of c-Myc gene expression.2. Materials and methods
2.1. Yeast two-hybrid screen
The reagents for the two-hybrid assay in yeast were obtained from Clontech
and the screening was performed following the manufacturer's protocols. Briefly
a cDNA fragment encoding the almost full-length alpha-enolase (aa 10–433) was
cloned in the pGBT9 vector in frame with the yeast GAL4 DNA binding domainand used as bait in AH109 yeast strain. Screening was performed by yeast mating
using a human bone marrow cDNA library in the pACT2 vector already pre-
transformed into yeast host strain Y187 (Matchmaker, Clontech). Positive yeast
colonies were identified by activation of reporter genes (HIS3, ADE2) in the
appropriate culture medium and tested for beta-galactosidase activity. Yeast
plasmid DNAwas isolated from positive colonies and electro-transformed into
Escherichia coli DH5α for plasmid amplification. The resulting DNA was re-
transformed into the bait-containing yeast strain and assayed again for specific
interaction. The cDNA inserts were further characterized by sequencing and
searching for sequence similarity in the GenBank database (www.ncbi.nlm.nih.
gov/BLAST/).
2.2. Plasmid constructs
The construction of the GST-Eno plasmid expressing alpha-enolase fused
to glutathione S-transferase (GST) has been described [16]. The same 1.35-kb
cDNA fragment inserted into the GST-3X vector (Amersham) to obtain the
GST-Eno plasmid was cloned into the BamHI/PstI sites of the pGBT9 vector
(Clontech) to generate the bait expression plasmid used for the two-hybrid
screen. For in vitro transcription–translation the p50/1 cDNA insert was
transferred with the original HA-tag into the pCDNA3 vector (Invitrogen),
whereas the p59/1 insert [23] was cloned into the pET-3a vector (Stratagene).
The full-length NS1-BP coding sequence was obtained by PCR using as
template the pQE30-NS1-BP vector (Wolff T., unpublished data) and cloned
into the pCDNA4/V5-His vector (Invitrogen). Similarly, constructs 50/1 and
59/1 in Fig. 1D were obtained by PCR amplification with appropriate oligo-
nucleotides and subsequent cloning into the pCDNA4/V5-His vector. All the
forward primers contained a Kozak sequence for proper translation initiation.
The Flag-Eno and Flag-MBP-1 expressing constructs were generated by PCR
amplification of the full-length or the Δ-NH2 (aa 97–433) enolase coding
sequence, using as template the alpha-enolase cDNA clone pH48 [4]. PCR
fragments were cloned into the pFlag-CMV-2 vector (Sigma). All the expression
constructs derived by PCR were sequenced to verify the open reading frame.
The IPP construct in the pGEM-T vector (Promega) has been described
previously [26]. Constructions of the pRC-ENO1-97 vector expressing MBP-1
and the pGL-cmp luciferase reporter plasmid, carrying the c-Myc gene promoter
region surrounding the P2 transcription start site, have been described elsewhere
[16].
2.3. Cell culture and transfection
Human embryonic kidney 293Tcells, human PAF fibroblasts, COS7 andHeLa
cells from laboratory stocks were grown in Dulbecco's modified Eagle's medium
(DMEM; Sigma) supplemented with 10% fetal bovine serum (Euroclone), 100
units/ml penicillin, and 100 μg/ml streptomycin in a 5% CO2 atmosphere. Cells
were transfected with the indicated plasmid DNAs using FuGene6 (Roche) or
Lipofectamine 2000 (Invitrogen) reagents according to the manufacturer's
instructions. In some cases the 293Tcells were transfected by the standard calcium
phosphate precipitation method as described previously [27].
2.4. In vitro interaction assay: GST pull-down assay
GST-alpha-enolase fusion protein was produced in E. coli strain XL1Blue as
described previously [16] and isolated by binding to glutathione-Sepharose 4B
(Amersham), the approximate amount of recombinant protein bound to the
beads was determined by SDS-PAGE and Coomassie blue staining.
In vitro transcription–translation was performed in the presence of [35S]-
methionine (1000 Ci/mmol-Amersham) using the TNT coupled transcription–
translation system (Promega) according to the manufacturer's instructions. In vitro
translated proteins (5-15 μl) were incubated for 4 h at 4 °Cwith GSTorGST-alpha-
enolase bound to glutathione-Sepharose beads (10 μl) in a 150 μl total volume of
binding buffer (150 mM NaCl, 10 mM TRIS pH 7.5, 1 mM DTT, 1 mM EDTA,
10%glycerol, 1%Nonidet P-40) containing protease inhibitors (Roche). The beads
were washed three times in washing buffer (150 mM NaCl, 10 mM TRIS pH 7.5,
1 mM DTT, 1 mM EDTA, 10% glycerol, 0.2% Nonidet P-40). Bound proteins
were eluted in 20 μl of Laemmli sample buffer (50 mM Tris pH 6.8; 2% SDS; 5%
2-Mercaptoethanol; 0.02% Bromophenol Blue), resolved by SDS-PAGE and
visualized by autoradiography.
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cells (1.5×106 per 100-mm dish) were transfected with 20 μg of the pNS1-BP/
V5 expression vector by calcium-phosphate precipitation. Cells were harvested
48 h later and lysed in 600 μl of binding buffer. The cellular extract (300 μl) was
incubated with GST or GST-alpha-enolase Sepharose beads as described above.
After the usual washing steps, beads were resuspended in Laemmli buffer and
the eluted proteins were analyzed by SDS-PAGE and immunoblotting.
2.5. Antibodies, coimmunoprecipitation and immunoblotting
The generation of the rabbit polyclonal anti-NS1-BP serum against amino
acids 1–368 and affinity purification of NS1-BP-specific antibodies have been
described elsewhere [23]. Anti-α-tubulin and anti-β-actin monoclonal anti-
bodies, mouse monoclonal and rabbit polyclonal anti-Flag (M2) antibodies were
from Sigma; anti-myc antibody was from Santa Cruz, anti-V5 monoclonal
antibody was obtained from Invitrogen. The anti-alpha-enolase rabbit
polyclonal serum and the 19-8 mouse monoclonal antibody against alpha-
enolase have been described previously [4,8].
For coimmunoprecipitation assays of ectopically expressed proteins, cells
were harvested at 48 h following transfection with Flag- and V5-tagged
expression vectors. Whole cell extract was prepared by lysis in a buffer (10 mM
Tris pH 7.6, 150 mM NaCl, 1 mM EDTA) containing 1% NP-40 and protease
inhibitor mixture (Roche). For coimmunoprecipitation of endogenous proteins
(enolase and actin) cells were lysed in 50 mM Tris–HCl pH 7.6, 150 mM NaCl,
1% NP40, 0.25% NaDOC supplemented with protease inhibitors (Roche) and
phoshatases inhibitors (Sigma).
Cytoplasmic and nuclear extracts were prepared as described by Brackertz et al.
[28]. Briefly, cells were resuspended in 3 volumes of lysis buffer 1 (20mMHEPES,
pH 7.9, 10 mM KCl, 1 mM EDTA, 10% glycerol, 0.2% Nonidet P-40,) and
incubated for 5min on ice. After centrifugation at 1250×g for 5min, the supernatant
(cytoplasmic fraction) was transferred into a fresh tube, the crude nuclear pellet was
resuspended in 2 volumes of lysis buffer 2 (420mMNaCl, 20mMHEPES, pH 7.9,
10 mM KCl, 1 mM EDTA) and incubated at 4 °C for 40 min under rotation. The
extract was centrifuged at 20,000×g for 15 min and the supernatant (nuclear
fraction) was diluted with 3 volumes of dilution buffer (10 mM KCl, 20 mM
HEPES, pH 7.9, 1 mM EDTA). In some experiments the crude nuclear pellet was
washed once in 0.6 volumes of lysis buffer 1 before nuclear proteins extraction. All
the buffers used for cellular fractionation contained a protease inhibitor mixture
(Roche). Protein concentrations were determined by the Bradford method using a
commercially available kit (Bio-Rad).
About 500μg of nuclear extract, 1.5–2.5mg of cytoplasmic or total cell extracts
were incubated overnight with 2 μg of rabbit anti-Flag or mouse anti-V5 antibodies
or preimmune antibodies as a control. To immunoprecipitate endogenous proteins
rabbit anti-NS1-BP antibodies (2 μg) or anti-alpha-enolase 19-8 affinity purified
antibody (2 μg) were used.
The immunocomplexes were collected with protein A/G-agarose beads (Santa
Cruz) and washed five times in washing buffer (200 mMNaCl, 20 mMTris–HCl,
pH 8.0, 1 mM EDTA, and 0.5–1% Nonidet P-40). The immunoprecipitated
proteins were eluted by incubating for 2 min at 95 °C in Laemmli sample buffer,
separated by SDS-PAGE and analyzed by immunoblotting as described previously
[29]. Briefly, proteins were electrotransfered to nitrocellulose (Amersham) or
PVDF (Millipore) membranes, after blocking, filters were incubated with mouse
anti-Flag (0.4 μg/ml) or anti-V5 (0.1 μg/ml) monoclonal antibodies. Alternatively,
both ectopically expressed and endogenous proteins were detected using affinity-
purified rabbit anti-NS1-BP polyclonal antibodies (1–2μg/ml) andmouse or rabbit
anti-alpha-enolase antibodies. Primary antibodies were revealed with horseradish
peroxidase-linked secondary antibodies (Amersham) and an ECL detection system
(Pierce). Plasmid constructs coding for V5-tagged irrelevant proteins, used as
controls, were pBERF 1.0 and pBERF 1.9 (Giallongo et al. unpublished) con-
taining deletion mutants of the ZBP-89 factor [29].
2.6. Immunofluorescence and microscopy
Human cells, HeLa or PAF fibroblasts, were seeded onto glass coverslips in a
12-well plate culture vessel about 24 h prior transfection with 0.75 μg of plasmid
DNA. After 48 h cells were fixed with 3.7% paraformaldehyde in phosphate-
buffered saline (PBS) and then permeabilized with 0.3%TritonX-100 in PBS. To
detect endogenous proteins affinity purified anti-NS1-BP rabbit polyclonalantibodies (10 μg/ml) or mouse monoclonal anti-alpha-enolase (7.5 μg/ml) were
used as primary antibodies. To detect ectopically expressed tagged-proteins the
cells were incubated with mouse anti-V5 (3 μg/ml), or rabbit anti-Flag (5 μg/ml)
primary antibodies in PBS containing 0.2% Tween 20. AlexaFluor 488-
conjugated goat anti-rabbit IgG and AlexaFluor 594-conjugated goat anti-mouse
IgG (Invitrogen) at a dilution of 1:500 were used as secondary antibodies. F-actin
was labeled with TRITC-conjugated phalloidin (Sigma). DNA was counter-
stained with 4′6-diamidino-2-phenylindole (DAPI) and the coverslips were
mounted onto glass slideswith Slowfade reagent (Invitrogen). Primary-antibody-
omission demonstrated specificity of the immunostaining. Immunofluorescence
microscopy was performed using a Leica DM-RA2 microscope equipped with a
high-performance charge-coupled device camera (Cohu, Inc., Electronics
Division, San Diego, USA). Cells were also imaged using a Leica TCS SPE
confocal laser-scanning microscope and confocal optical sections were created
using Leica confocal software.
2.7. Luciferase reporter assay
COS7 cells (6×104) were transfected with 300 ng of the pGL-cmp luciferase
reporter construct and 250 ng of the β-galactosidase expressing vector PON1 [27]
used as internal control plasmid tomonitor transfection efficiency. In cotransfection
experiments 100 ng of the pRCENO1–97 and 10–70 ng of the pNS1-BP/V5 or 50/
1 effector vectors were used. The total amount of vector DNAwas kept constant by
balancing with the empty expression plasmid. The transfected cells were lysed in
passive lysis buffer (Promega) and luciferase activities were detected with a Lumat
LB 9507 luminometer (Berthold Technologies) using the luciferase assay system
(Promega). All transfections were performed in triplicate and results from three
independent experiments are expressed as mean±SD.
2.8. Total RNA isolation and quantitative real-time PCR
Total RNA was extracted using the Trizol reagent according to the
manufacturer's instructions (Invitrogen) and reverse-transcribed into cDNA by
using Superscript II reverse transcriptase (Invitrogen) as described previously
[30]. Amplification reactions were performed in a 25 μl reaction volume con-
taining about 20 ng total RNA equivalents, 10 pmoles of each primer (c-Myc,
forward -TAC CCT CTC AAC GAC AGC AG, reverse - TCT TGA CAT TCT
CCT CGG TG) and the FluoCycle (Celbio, IT) SYBER Green hot-start Taq
ready-mix, according to manufacturer's suggestions. To correct for the expe-
rimental variations between samples, oligonucleotide primers for glyceralde-
hyde-phosphate-dehydrogenase (GAPDH) were included in each PCR reaction
(forward -TGACAT CAAGAAGGTGGTGA, reverse - TCCACCACCCTG
TTG CTG TA). Real-time PCR was performed in a SmartCycler system II
(Chepheid). All data shown were generated from three independent experiments
and are expressed as mean±SD.
2.9. Statistical analysis
A one-way analysis of variance (ANOVA) was used to compare the effect of
MBP-1 and NS1-BP proteins on reporter activity and endogenous c-Myc
expression. Statistical analyseswere performed using StatsDirect Ver.2.5.1 program
(StatsDirect, Ltd, UK) and results were considered significant if the p value
was b0.05.
3. Results
3.1. Isolation of NS1-BP as a protein interacting with
alpha-enolase
To identify potential partners of the alpha-enolase protein and
its MBP-1 variant, we performed a yeast two-hybrid screening
using the full length alpha-enolase as bait and a human bone
marrow cDNA library. Eleven positive clones were initially
isolated out of 3.5×106 independent clones, but only two sur-
vived rounds of back transformation and further screening.
Fig. 1. Interaction between NS1-BP protein and alpha-enolase. (A) Schematic representation of NS1-BP showing the deletion constructs used. Upper bar: full-length
NS1-BP. The cross-hatched box and the squared box indicate the BTB/POZ domain and the BACK domain, respectively; the black boxes represent the six kelch
repeats. Lower bars: full-length construct (NS1-BP), partial clone isolated by two-hybrid screen in yeast using alpha-enolase as bait (50/1), partial clone previously
isolated by two-hybrid screen using NS1 (59/1) [23], unrelated kelch-repeat protein (IPP) [26]. Numbers indicate the first and last amino acid in each construct. (B) In
vitro binding of enolase to full-length NS1-BP and deletion mutants. Equivalent amounts of in vitro-translated [35S]-Met-labeled NS1-BP, 50/1, 59/1 and the unrelated
IPP protein, were incubated with GST coupled to glutathione-Sepharose beads (GST) or beads carrying GST-alpha-enolase (GST-Eno) [16]. Bound proteins were
separated by SDS-PAGE and visualized by autoradiography. Twenty percent of each in vitro-translated protein was loaded on the same gel (Input). (C) GST pull-down
of in vivo synthesized NS1-BP. 293T cells were transiently transfected with the pNS1-BP/V5 construct, encoding V5-tagged NS1-BP. Total lysates were incubated
with GST or GST-Eno beads and the eluted proteins analyzed by immunoblotting (Blot) using anti-V5 monoclonal antibody. To control level of ectopically expressed
protein 4% of the total lysate was loaded on the same gel (Input). V5-tagged NS1-BP was found specifically associated with GST-Eno. (D and E) In vivo binding of
enolase to full-length NS1-BP and deletion mutants. (D) V5-tagged NS1-BP, 50/1, 59/1 polypeptides and irrelevant BERF1.0 protein were transiently expressed in
293T cells, whole-cell extracts were immunoprecipitated (IP) with anti-V5 monoclonal antibodies and precipitated proteins visualized by immunoblotting. Note that
V5-tagged 50/1 migrates on SDS-PAGE slower than the HA-tagged 50/1 shown in panel B, however, two major polypeptides were detected both in vitro and in vivo.
The asterisk (⁎) indicates anti-V5 immunoglobulins. (E) Association of endogenous alpha-enolase to ectopically expressed NS1-BP polypeptides. Immunoprecipitates
from 293T cells expressing the V5-tagged polypeptides shown in panel D were analyzed by immunoblotting using anti-alpha-enolase polyclonal antibodies. The
asterisk (⁎) indicates crossreaction with anti-V5 immunoglobulins. Enolase was specifically coimmunoprecipitated with full-length NS1-BP and 50/1 polypeptide.
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that one of these clones, named 50/1, encoded a partial protein of
365 amino acids (aa) corresponding to the carboxyl-terminal
portion of NS1-BP [23]. The coding region is followed by a 263-
bp-long 3′-untranslated sequence. NS1-BP belongs to the kelch
protein superfamily, the full-length protein (642 aa) contains at the
C-terminus six canonical kelch repeats (47–49 amino acids) and
at the N-terminus a BTB/POZ domain (aa 1–128) followed by
recently identified BACK domain (aa 134–233) [31]. The 50/1
clone encodes a protein with an apparent molecular mass of
approximately 40 kDa that contains the six kelch tandem repeats
but lacks both BTB/POZ and BACK domains (Fig. 1A). Initially,
we confirmed a physical interaction between alpha-enolase and
NS1-BP in a cell-free system by GST pull-down assay. [35S]-
methionine-labeled full-length NS1-BP and deletion mutants
were produced by in vitro transcription and translation, and
allowed to interact with recombinant GST-alpha-enolase fusion
protein immobilized on glutathione-Sepharose beads. Consis-
tently with the two-hybrid assay results, the polypeptide encoded
by the isolated clone 50/1 (aa 277–642) and the wild-type NS1-
BP protein interacted with alpha-enolase in vitro (Fig. 1B). The
50/1 construct gave rise to two major products, probably
originated from breakdown or usage of alternative initiator
methionines. Only the slower-migrating 50/1 polypeptide
associatedwithGST-enolase, suggesting difference in the binding
activity due to sequence and/or structure of each product.
NS1-BP and both 50/1 translation products did not bind to
glutathione-Sepharose beads carrying recombinant GST and an
unrelated but structurally similar kelch protein (IPP [26]) did not
interact with GST-enolase (Fig. 1B). Thus, both results confirmed
the specificity of the interaction. Under identical experimental
conditions a truncated NS1-BP protein (aa 347–642), encoded by
clone 59/1 [23], did not bind the GST-fusion protein suggesting
that amino acid sequence from 277 to 347 is required for the
specific interaction between NS1-BP and alpha-enolase.
To provide further evidence of the NS1-BP–alpha-enolase
association, a GST pull-down assay was performed using cellular
extracts. Immobilized GSTand GST-enolase were incubated with
total lysate from 293T cells previously transfected with an ex-
pression construct encoding V5-tagged NS1-BP (see Fig. 2A for
construct details). Each GST-bound fraction was subjected to
immunoblot analysis with anti-V5 antibody. Consistentlywith the
results obtained using the in vitro-translated proteins, NS1-BP
was specifically detected only in the GST-enolase-bound fraction
(Fig. 1C).
Subsequently, in order to investigate in vivo the interaction
between the amino acid sequence 277–347 and alpha-enolase,
V5-taggedNS1-BP, 50/1 and 59/1 polypeptideswere individually
expressed in 293Tcells. The relative expression levels of the three
NS1-BP variants and the unrelated control protein (BERF1.0)
were assessed by immunoprecipitation and immunoblot analysis
(Fig. 1D). Endogenous alpha-enolase was coimmunoprecipitated
from cells ectopically expressing either full-length NS1-BP or the
50/1 polypeptide, whereas alpha-enolase was not found associ-
ated with the 59/1 polypeptide or BERF1.0 protein (Fig. 1E).
These results confirmed the GST-pull-down data and demon-
strated that the region adjacent to the kelch repeats is criticallyinvolved in the interaction between NS1-BP and alpha-enolase.
Notably, the amino acid sequence 277–347 might be directly
involved in the binding and/or contribute to proper folding of
the protein. There was not detection of endogenous MBP-1 in
the precipitate from total lysate of transfected cells (data not
shown), probably due to the small amount of MBP-1 com-
pared to the alpha-enolase expression levels in mammalian
cells [16].
3.2. NS1-BP interacts with both alpha-enolase and MBP-1 in
vivo
To further investigate the in vivo interactions between alpha-
enolase/MBP-1 and NS1-BP, we generated constructs expres-
sing Flag-tagged enolase or MBP-1 (Fig. 2A); the amounts of
plasmids used for cotransfection were then adjusted to ensure
comparable expression levels (Fig. 2B).
Results obtained from 293T cells transiently transfected with
constructs encoding V5-tagged NS1-BP and Flag-tagged enolase
are shown in Fig. 2C. Protein complexes associated with enolase
were immunoprecipitated from whole-cell lysate using anti-Flag
antibody and subsequently analyzed by immunoblotting with
anti-V5 antibody. NS1-BP was specifically coprecipitated with
enolase, whereas no protein was detected using a preimmune
antibody (Fig. 2C, lower panel), or an unrelated Flag-tagged
protein (data not shown). These results confirmed that the two
proteins form a complex in vivo.
To investigatewhetherNS1-BP could also interactwithMBP-1,
which lacks the first 96 amino acids [15,16], coimmunoprecipita-
tion experiments were carried out using nuclear and cytoplasmic
extracts from 293Tcells ectopically expressingV5-taggedNS1-BP
and Flag-tagged MBP-1. Both proteins were recovered in cyto-
plasmic and nuclear fractions of the transfected cells (Fig. 2D,
upper panel). Interestingly ectopically expressed MBP-1 seems to
form a specific complex with NS1-BP in both nuclear and cy-
toplasmic compartments of cotransfected cells (Fig. 2E). Proper
cell fractionation was assessed by the use of antibodies against
a nuclear marker, the transcription factor ZBP-89 [29], and a
commonly used cytoplasmic marker, tubulin. In addition, anti-
bodies that react with alpha-enolase were also used (Fig. 2D, lower
panel). Detection of endogenous MBP-1 was hampered by the
presence of the overexpressed Flag-taggedMBP-1 that comigrates
on SDS-PAGE (compare lane Ip Eno and Control in Fig. 2F, lower
panel).
To further confirm interaction between MBP-1 and NS1-BP
in vivo we performed coimmunoprecipitation of proteins
extracted from untransfected human cells. As shown in Fig 2F
endogenous NS1-BP was coimmunoprecipitated from the
nuclear fraction using an anti-alpha-enolase monoclonal anti-
body that recognizes both full-length alpha-enolase and the
MBP-1 variant. This result confirmed a specific association of
MBP-1 with NS1-BP into the nucleus of human cells and the
data demonstrated all together that NS1-BP is able to interact
with alpha-enolase as well as with the MBP-1 variant.
Coimmunoprecipitation of the cytoplasmic fraction, where
alpha-enolase is abundant and easily recovered, failed to bring
down NS1-BP (data not shown). Probably the difference in
Fig. 2. In vivo association of NS1-BP with alpha-enolase and its MBP-1 variant. (A) Schematic representation of the V5- and Flag-constructs, cross-hatched and black
boxes indicate the position of the epitopes. Numbers indicate the first and last amino acid in each construct. (B) Total lysates from 293Tcells cotransfected with the V5-
construct (NS1-BP) and Flag-constructs (Eno or MBP-1, lane 1 and 2, respectively) were separated by SDS-PAGE. Upper panel, immunoblot with anti-V5 monoclonal
antibody. Lower panel, immunoblot with anti-Flag monoclonal antibody. (C) In vivo association between ectopically expressed alpha-enolase and NS1-BP. Whole-cell
extracts from 293T cells expressing Flag-Eno and NS1-BP/V5 were immunoprecipitated (IP) with anti-Flag polyclonal antibody (IP Flag) or preimmune antibody (IP
IgG) and analyzed by immunoblotting using anti-Flag (upper panel) or anti-V5 monoclonal antibody (lower panel). Input represents 2.5% of the cell extract used for
each IP sample. NS1-BP was specifically coimmunoprecipitated with alpha-enolase. (D) Subcellular fractionation of 293T cells transfected with pFlag-MBP-1 and
pNS1-BP/V5. Upper panel, cytoplasmic (Cyt.) and nuclear (Nuc.) fractions were applied to SDS-PAGE followed by immunoblotting with anti-V5 or anti-Flag
monoclonal antibody. Lower panel, anti-ZBP-89 antibodies (nuclear fraction marker), anti-tubulin and anti alpha-enolase (cytoplasmic fraction markers) were used to
estimate proper fractionation. Note that the cytoplasmic fraction is one-fourth cell equivalents with respect to the nuclear fraction. (E) In vivo association between
ectopically expressed MBP-1 and NS1-BP. Subcellular fractions were immunoprecipitated with anti-V5 monoclonal (IP V5) or anti-Flag (IP Flag) polyclonal
antibodies, preimmune immunoglobulins were used as a negative control (IP IgG). Upper panel, NSI-BP/V5-immunoprecipitates from cytoplasmic and nuclear
fractions were analyzed by immunoblotting using anti-Flag antibodies. Lower panel, immunoblot of Flag-MBP-1-immunoprecipitates with anti-V5 monoclonal
antibodies. Input represents 2.5% of the cell extract used for each IP sample. MBP-1 was coimmunoprecipitated with NS1-BP from cytoplasmic and nuclear fractions.
(F) in vivo association of endogenous proteins. Nuclear extracts from untransfected 293T cells were immunoprecipitated with anti-alpha-enolase monoclonal
antibodies (IP Eno) or preimmune matched-isotype immunoglobulins (IP IgG). Total lysate from cells overexpressing Flag-MBP-1 and NS1-BP/V5 was loaded on the
same gel as a control (control). Upper panel, immunoprecipitates were analyzed by immunoblotting using rabbit anti-NS1-BP-specific antibodies. Lower panel,
immunoblot of the same immunoprecipitates with mouse anti-alpha-enolase. The asterisk (⁎) indicates a minor cross-reacting band. Endogenous NS1-BP was
coimmunoprecipitated with MBP-1 from the nuclear fraction.
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of the protein complex in this cellular compartment.
3.3. Association of NS1-BP with actin
NS1-BP has been originally described as a protein interacting
with the nonstructural NS1 protein of the influenza A virus and
playing a role in pre-mRNA splicing [23]. Both NS1 interaction
and splicing are functions taking place in the nucleus. Recently,
one NS1-BP short form has been identified in mice, Nd1-S,
which shares with the human NS1-BP protein and the mouse
counterpart (originally named Nd1-L), the BTB/POZ and
BACK domains but lacks the kelch repeats. Nd1-L and Nd1-S
are encoded by the same gene [32]. It has been reported that in
murine cells and tissues Nd1-L is ubiquitously expressed and
mainly localizes in the cytoplasm where it functions as a sta-bilizer of actin filaments [33]. In contrast, the ectopically
expressed Nd1-S is primarily located in the nucleus and it has
been proposed a functional role in cell cycle progression [34].
Such variant protein has not been identified in human cells,
although mRNA sequences potentially encoding this short
polypeptide are deposited in the GenBank database (see acces-
sion number NM_016389). In our hands, transfection of human
cells with an expression vector carrying the mouse Nd1-S
sequence resulted in barely detectable levels of ectopically
expressed protein, suggesting a very short half-life of this variant
form (data not shown).
Association of kelch repeats with actin is a common feature of
several BTB-kelch proteins [24]. In order to clarify the involvement
of NS1-BP in cytoskeleton organization and to assess a functional
correlation with murine Nd1L, we investigated its association with
actin by overexpressing V5-tagged NS1-BP in human 293T cells.
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NS1-BP (Fig 3A,middle panel) indicating an in vivo association of
the two proteins. As expected, endogenous alpha-enolase was also
detected in the immunoprecipitated complex (Fig 3A, lower
panel), whereas neither actin nor enolase were coimmunoprecipi-
tated with an unrelated V5-tagged protein (BERF1.9) used as a
control. The same results were obtained using lysates from cells
expressing the V5-tagged 50/1 polypeptide (Fig 3A), confirming
that kelch repeats located in the C-terminus of NS1-BP are
necessary for the association with actin.
Furthermore, to investigate the colocalization with actin
cytoskeleton, fluorescent phalloidin was used to visualize fila-
mentous actin (F-actin) in human fibroblasts transiently expres-
sing V5-tagged NS1-BP (Fig. 3B). Staining assay to visualize the
ectopic NS1-BP was positive throughout the cytoplasm (Fig. 3B,
panel b), whereas actin and NS1-BP colocalized in fibrillar stress
fibers (Fig. 3B, panel d, and arrows in inset e).
3.4. Subcellular localization of alpha-enolase, MBP-1 and
NS1-BP in intact cells
Affinity purified NS1-BP-specific antibodies have been pre-
viously used in immunofluorescence analysis of HeLa cells and
resulted in weak but consistent staining of the cytoplasm and a
major punctuate nuclear staining, indicating a nuclear speckles
localization. Moreover, in influenza A virus-infected cells NS1-
BP has been shown to relocalize throughout the nucleoplasm [23].
To further characterize NS1-BP association with alpha-
enolase and MBP-1, we first investigated the subcellular loca-
lization of endogenous proteins in human fibroblasts by indirect
immunofluorescence (Fig. 4A). We observed both nuclear andFig. 3. In vivo association of NS1-BP with actin. (A) 293T cells were transfected with
lysates were immunoprecipitated with anti-V5 monoclonal antibody (IP V5). Immuno
alpha-enolase antibodies. Input represents 2.5% of the cell extract used for each IP sam
BP and 50/1 polypeptides. (B) NS1-BP colocalization with F-actin. Human PAF fibro
stained with TRITC-phalloidin (panel a) and anti-V5 antibody (panel b), as describ
distribution was visualized by confocal microscopy as described in Materials and met
composite images revealed colocalization of NS1-BP with fibrillar stress fibers (arrocytoplasmic staining using either anti-alpha-enolase monoclonal
antibody or affinity-purified anti-NS1-BP polyclonal antibody.
Immunofluorescence staining for enolase/MBP-1 appeared to be
strong and diffuse throughout the cytoplasm and weak in the
nucleus (Fig. 4A, panel a), whereas NS1-BP exhibited a predo-
minant nuclear and perinuclear localization (Fig. 4A, panel b). The
merged image indicated colocalization of the endogenous proteins
in both cellular compartments (Fig. 4A, panel d).
To support and confirm the previous observations concerning
nuclear localization of NS1-BP in another cell type, the p66
component of the MeCP1 complex was coexpressed with V5-
tagged NS1-BP in human fibroblasts. The p66 is a well-cha-
racterized zinc finger protein displaying a typical nuclear speckle
pattern of expression [35]. As expected, confocal analysis of cells
expressing Flag-tagged p66 gave a speckled staining pattern in the
nucleus (Fig. 4B, panel a), whereas ectopically expressed NS1-
BP was found in both cytoplasmic and nuclear compartments
(Fig. 4B, panel b). The merged image confirmed colocalization of
NS1-BP and p66 in specialized nuclear structures with exclusion
of the nucleoli (Fig. 4B, panel d).
Next, we studied the localization of Flag-Eno, Flag-MBP-1
and NS1-BP/V5 in human fibroblasts. As expected, enolase was
predominantly found in the cytoplasm (Fig. 4C, panel a), whereas
MBP-1 showed an additional nuclear localization (Fig. 4C,
compare panel c and a). Ectopically expressed NS1-BP gave the
usual staining in both cellular compartments (Fig. 4C, panel e).
Further colocalization assays were performed coexpressing
NS1-BP with alpha-enolase or MBP-1 and subsequently cells
were double stained with specific antibodies (Fig. 4D). The
merged images confirmed that NS1-BP colocalizes with both
alpha-enolase and MBP-1. The MBP-1/NS1-BP-positive cellsNS1-BP/V5, V5-tagged 50/1 or control BERF1.9 expression plasmids and cell
precipitates were analyzed by immunoblotting using anti-V5, anti-actin and anti-
ple. Actin and alpha-enolase were specifically coimmunoprecipitated with NS1-
blasts transiently expressing NS1-BP/V5 were fixed, permeabilized and double-
ed in Materials and methods. Nuclei were stained with DAPI (panel c). Spatial
hods. The image in panel d is the merged image of those in panels a and b. Color
ws in inset e). Bar, 10 μm.
Fig. 4. Intracellular localizations of alpha-enolase, MBP-1 and NS1-BP. (A) Immunofluorescent microscopy localization of endogenous enolase and NS1-BP proteins.
Human PAF fibroblasts were fixed, permeabilized and double-stained with mouse anti-alpha-enolase (panel a) and rabbit anti-NS1-BP (panel b) primary antibodies as
described inMaterials andmethods. Panel d shows the merged image of those in panels a and b. Counterstaining with DAPI was used to identify nuclei (panel c). Bar, 10 μm.
(B) Nuclear speckles colocalization of NS1-BP and p66 proteins. Human PAF fibroblasts were cotransfected with vectors expressing Flag-p66 and NS1-BP/V5 and
immunostainedwith rabbit anti-Flag (panel a) andmouse anti-V5 (panel b) primary antibodies. CounterstainingwithDAPIwas used to identify nuclei (panel c). Panel d shows
themerged image of those in panels a and b. Spatial distributionwas visualized by confocalmicroscopy as described inMaterials andmethods. Bar, 10μm. (C) Localization of
individually expressed tagged proteins. Human PAF fibroblasts were transfected with vectors expressing either Flag-Eno, Flag-MBP-1 or NS1-BP/V5 proteins as indicated.
The Flag-Eno-positive cells display a stronger cytoplasmic staining compared to the Flag-MBP-1-positive cells (compare panels a and c). Flag-MBP-1- and NS1-BP/V5-
overexpressing cells display both cytoplasmic and nuclear staining (panel c and panel e, respectively). DAPI was used to identify nuclei (panels b, d and f). Bar, 10 μm.
(D) Colocalization of ectopically expressed proteins. Human PAF fibroblasts were cotransfected with vectors expressing Flag-Eno and NS1-BP/V5 (panels a–d) or Flag-
MBP-1 and NS1-BP/V5 (panels e–h). Nuclei were labeled with DAPI (panels c and g). Spatial distribution was visualized by confocal microscopy as described in Materials
andmethods. In themerged images, theMBP-1/NS1-BP-positive cells display a strong nuclear double-staining suggesting thatMBP-1 andNS1-BPmainly colocalize into the
nucleus, conversely a diffuse staining throughout the cytoplasm is indicative of alpha-enolase and NS1-BP colocalization (compare panels d and h). Bar, 10 μm.
1781G. Perconti et al. / Biochimica et Biophysica Acta 1773 (2007) 1774–1785showed a strong nuclear double-staining (Fig. 4D, panel h),
indicating that MBP-1 and NS1-BP mainly colocalize in the
nucleus, conversely, a diffuse staining throughout the cytoplasm
was indicative of alpha-enolase and NS1-BP colocalization
(Fig. 4D, panel d). Similar results were obtained in HeLa cells
(data not shown). Altogether our results are consistent with
complex formations in distinct cellular compartments.3.5. NS1-BP enhances c-Myc gene transcriptional repression
exerted by MBP-1
MBP-1 has been described as a transcriptional repressor of the
c-Myc gene and several lines of evidence support its involvement
in the control of cell proliferation. To determine the functional role
of NS1-BP on MBP-1-mediated transcriptional repression, we
Fig. 5. Synergistic effects of MBP-1 and NS1-BP on c-Myc promoter. (A)
Schematic representation of the pGL-cmp reporter plasmid that contains the c-Myc
promoter upstreamof the firefly luciferase gene [16]. (B)COS7 cellswere transiently
transfected with the pGL-cmp construct and either vectors expressing MBP-1
(100 ng pRC-EN0-1-97) or NS1-BP (10–70 ng pNS1-BP/V5) or both as indicated.
Luciferase activities of the pGL-cmp reporter plasmid, in the absence or presence of
MBP-1 and increasing amounts of NS1-BP, were corrected for differences in
transfection efficiencies and compared with the activity observed using an insertless
effector plasmid (mock transfected, black bar). NS1-BP augmentsMBP-1 effects on
a c-Myc promoter driven reporter. Asterisks indicate values significantly different
(pb0.01) from those ofmock-transfected cells; hyphen indicates values significantly
different (pb0.01) from those ofMBP-1 transfected cells. The data are averages of at
least three independent experiments and the error bars represent SD.
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plasmid containing the c-Myc promoter upstream of the luciferase
gene. The results shown in Fig. 5 indicated that ectopic expression
of NS1-BP enhances the inhibitory effect of MBP-1 on c-MycFig. 6. Coexpression of MBP-1 and NS1-BP negatively regulates endogenous c-Myc
levels. Human PAF fibroblasts were transfected either with vectors expressing MBP-1
after transfection cells were harvested for RNA extraction. The abundance of the endo
results are expressed relative to the c-Myc mRNA level in cells transfected with an in
100%. The data are averages of three independent experiments and the error bars repr
mock-transfected cells; hyphen indicate values significantly different (pb0.01) from
cells. Lane 1, mock transfected cells. Lane 2, cells transfected with pFlag-MBP-1. La
expression was down regulated in cotransfected cells. β-actin was used as a controlpromoter activity. This effect was supported by the observed
dose-dependent response, in contrast no effect was detected
following overexpression of the 50/1 polypeptide that lacks the
BTB/POZ domain (data not shown); suggesting that NS1-BP
regulatory activity on c-Myc transcription might be mediated by
this protein–protein interaction domain.
To verify the biological significance of the in vitro promoter
studies, we investigated the effect of the concomitant ectopic
expression of NS1-BP and MBP-1 on endogenous c-Myc
expression. Human fibroblasts were transfected with vectors
overexpressingMBP-1 or NS1-BP or both proteins and the steady
state abundance of c-Myc transcripts was quantified by real-time
PCR. Consistent with the results obtained with the c-Myc
promoter-luciferase construct, the MBP-1-induced decrement in
mRNA level was significantly greater in cells coexpressing NS1-
BP as compared to cells transfected with the MBP-1 expression
vector alone (Fig. 6A). Analysis of the endogenous c-myc protein
revealed that a significant down-regulation of protein expression
occurs in cells coexpressingNS1-BP andMBP-1 (Fig. 6B, lane 3).
This result is in agreement with the decrease of c-Myc message
observed in the same cells.
The data presented support an in vivo physiological function
for the physical association of NS1-BP with MBP-1 in regulating
c-Myc gene expression.
4. Discussion
4.1. Alpha-Enolase, a multifunctional glycolytic enzyme,
interacts with a BTB-kelch protein
In this studywe demonstrated that the glycolytic enzyme alpha-
enolase and the MBP-1 variant associate with a member of the
kelch protein superfamily, named NS1-BP. Although glycolysis is
a cytoplasmic process alpha-enolase, unlike other glycolyticmRNA. (A) Effect of MBP-1 and NS1-BP overexpression on c-Myc transcript
(1 μg pFlag-MBP-1) or NS1-BP (1 μg pNS1-BP/V5) or both as indicated. 48 h
genous c-Myc transcript was measured by quantitative RT-PCR (Real-time). The
sertless expression vector (mock transfected, black bar), that was arbitrarily set at
esent SD. Asterisks indicate values significantly different (pb0.01) from those of
those of pFlag-MBP-1 transfected cells. (B) Immunoblot analysis of transfected
ne 3, cells transfected with both pFlag-MBP-1 and pNS1-BP/V5. c-Myc protein
for loading.
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addition to the high prevalence in the cytosolic compartment. Cell-
surface alpha-enolase functions as a strong plasminogen receptor
while the MBP-1 variant acts as a c-Myc transcriptional repressor
inside the nucleus. Since the enolase sequence lacks canonical
localization signals, we hypothesized that its interaction with
molecular partners might be required for alternative localizations
and functions. Therefore, in order to identify proteins interacting
with enolase we used the two-hybrid screening and as a result we
isolated NS1-BP, a BTB/POZ domain- and kelch repeats-
containing protein. Human NS1-BP has been originally isolated
as a protein interacting with the nonstructural NS1 protein of the
influenzaAvirus and the protein–protein interactionwas proposed
to occur within the nucleus of infected cells [23]. In murine cells
and tissues it has been shown that Nd1-L, themouse homologue of
NS1-BP, localizes in the cytoplasm where it functions as a
stabilizer of actin filaments [33]. In this work, we confirmed an
interaction between NS1-BP and actin, supporting multiple func-
tional roles for this kelch protein in human cells.
4.2. Known functions of BTB-kelch proteins
Many kelch repeats proteins are involved in the cytoskeleton
organization through association with actin filaments. The
Drosophila Kelch protein, representing the first acknowledged
member of the family, is a well characterized actin-binding
component of ring canals [36]. During evolution, this family of
proteins expanded with a major expansion of the subgroup that
contains both the BTB/POZ domain and kelch repeats [37]. The
BTB/POZ is an evolutionary conserved protein–protein inter-
action domain that is often present at the N-terminus of zinc
finger transcription factors. The biological function of the BTB
domain present in zinc finger proteins, such as B cell lymphoma
(BCL-6) and promyelocytic leukemia (PLZF) oncoproteins, has
been widely demonstrated. This function concerns a wide range
of cellular events such as transcriptional repression, transcrip-
tional activation and chromatin remodeling, with consequent
involvement in development, homeostasis and neoplasia [38].
Only recently the physiological and biochemical roles of some
kelch-related proteins, containing the BTB/POZ domain, have
been characterized.
Many kelch-related proteins like KLHL1/MRP2, KLHL2/
Mayven and NRP/B/Enc1 are predominantly expressed in
the brain and their involvement in neurite outgrowth has been
reported [39–41]. Physiological functions have also been
elucidated for Keap 1, which sequester Nrf2 transcription factor
in the cytoplasm, thus regulating the expression of downstream
genes encoding detoxifying and antioxidant proteins [42].
KlHL10, whose expression is restricted to spermatids, is required
for male fertility and, through interaction with Cullin3, mediates
protein ubiquitination during spermiogenesis [43,44]. KLHL6
has been shown to be involved in B-cell function [45]. Recently, a
growing number of reports have associatedBTB-kelch proteins to
cancer and neurodegenerative disorders. Genetic alterations of
NRP/B, leading to a reduced binding affinity to actin, have been
detected in brain tumors, andmutations in the gigaxonin encoding
gene have been found in patients affected by the giant axonalneuropathy [46,47]. To date the majority of the physiological
roles ascribed to kelch proteins are still related to the cytoskeleton
network. Previous studies concerning NS1-BP supported func-
tional roles in cytoplasmic and nuclear compartments, such as
stabilization of actin filaments and promotion of pre-mRNA
splicing [23,33]. Additionally, a recent report indicates that NS1-
BP interaction influences the cytosolic concentration of the aryl
hydrocarbon receptor, a ligand-activated transcription factor [48],
and the generation of animal models has elucidated a protective
role for NS1-BP/Nd1 expression in doxorubicin-induced cardio-
myopathy [49]. Results obtained in this study support the notion
of additional regulatory roles for NS1-BP.
4.3. Functions of the enolase/MBP-1–NS1-BP association
We have demonstrated that NS1-BP is able to enhance MBP-
1-mediated c-Myc gene transcriptional repression. Myc plays a
pivotal role in the transcription factors network controlling
cellular proliferation, growth, differentiation and apoptosis [50].
The gene encoding alpha-enolase (ENO1) has been identified as
a direct Myc target [51,52], suggesting that Myc-dependent
glycolysis may be regulated by negative-feedback via MBP-1
[11]. Thus, NS1-BP could be involved in this pathway con-
tributing to the nuclear localization of MBP-1. This hypothesis
is supported by our preliminary observation that ectopic
expression of NS1-BP results in an increased nuclear staining
using anti-alpha-enolase/MBP-1 antibodies (Fig. 4). Alterna-
tively, NS1-BP may directly participate to c-Myc transcriptional
regulation with MBP-1. Although MBP-1 domains involved in
transcriptional repression have been identified by transfection
assays [53], little is known about the molecular mechanisms
underlying the repression activity. It has been demonstrated that
MBP-1 physically associates with HDAC1, but the HDAC
inhibitor TSA partially interferes with MBP-1-mediated transcrip-
tional repression. HDAC activity seems only partially linked to
MBP-1-mediated transcriptional control and it has been suggested
that other unrelated and still unknown HDAC-independent
mechanisms could be involved in c-Myc negative regulation
[21]. Several BTB/POZ transcriptional regulators are known to
mediate transcriptional repression recruiting silencing mediators
and HDAC complexes to the promoter of the target gene.
Moreover, they contribute to chromatin architecture and remodel-
ing thanks to their ability to self-dimerize [54]. Hence, it may be
speculated that the NS1-BP BTB domain is important for the
assembly of the MBP-1 repression complex on c-Myc promoter.
In relation to the physiological implication of NS1-BP-
alpha-enolase interaction within the cytoplasmic compartment,
it has been reported that alpha- and beta-enolase are found
associated to cytoskeletal component like F-actin [55] or tubulin
[10]. Therefore, on the basis of our findings we suggest that
NS1-BP may be involved in the localization of a small fraction
of the cytosolic enolase in specific cell compartments.
Recently, it has been reported that in breast cancer cells the
BTB-kelch protein Mayven, originally identified as an actin-
binding protein, induces cyclin D1 expression and cyclin D1
promoter activity through its BTB/POZ domain [56]. NS1-BP as
Mayven protein seems to exert diverse functions depending on
1784 G. Perconti et al. / Biochimica et Biophysica Acta 1773 (2007) 1774–1785cellular localization, contributing to cytoskeleton dynamics and
transcriptional regulation.
Although further studies are needed in order to elucidate the
regulatory pathway and the molecular mechanisms underlying
the interplay among NS1-BP, alpha-enolase/MBP-1 and c-Myc,
this work provides the first evidence of a BTB-kelch protein
involvement in transcriptional regulation of a mammalian on-
cogene. These findings could provide new directions for bio-
chemical and functional studies on proteins containing BTB
domains and kelch repeats in cancer cells.
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